Drug profile · INN
dimethyl fumarate
APO-DIMETHYL FUMARATE
dimethyl fumarate (APO-DIMETHYL FUMARATE) is a kelch-like ech-associated protein 1 inhibitor. Associated with Biogen. Route of administration: oral. Current US regulatory status: approved.
Drug details — dimethyl fumarate
- US status
- approved
- Class
- Antineoplastic and immunomodulating agents (L04)
- Route
- ORAL
- Patents
- 1
- Programs
- 9
- Data quality
- 0.89
Quick answer
dimethyl fumarate (APO-DIMETHYL FUMARATE) is a kelch-like ech-associated protein 1 inhibitor. Associated with Biogen. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Kelch-like ECH-associated protein 1 inhibitor
Primary target: Kelch-like ECH-associated protein 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is dimethyl fumarate?
dimethyl fumarate (APO-DIMETHYL FUMARATE) is a kelch-like ech-associated protein 1 inhibitor. Associated with Biogen. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dimethyl fumarate?
APO-DIMETHYL FUMARATE is a marketed brand name for dimethyl fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dimethyl fumarate?
dimethyl fumarate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.